CYP450-GP

CYP450-GP is a privately held, revenue-generating reagent supplier founded in 2015 and based in Vista (San Diego area), California. The company has developed a proprietary portfolio of highly specific inhibitory antibodies targeting key drug-metabolizing cytochrome P450 enzymes, which are used by pharmaceutical companies and research labs for critical early-stage drug development studies. Its core product, the CYP Immunoinhibition Kit, provides a standardized solution for reaction phenotyping, a regulatory requirement. With a lean operational model and deep expertise in P450 biology, the company serves a niche but essential segment of the drug development tools market.

Proprietary generation of monospecific, inhibitory polyclonal antibodies against human cytochrome P450 enzymes, plus purified enzyme components, for in vitro drug metabolism reaction phenotyping.

CYP450-GP competes in a specialized niche against the in-house reagent divisions of large pharmaceutical companies and broad-line life science suppliers (e.g., Thermo Fisher, Corning) that offer chemical inhibitors and some antibodies. Its competitive advantage lies in deep expertise, proven antibody specificity for inhibition, and a focus on regulatory-grade tools, unlike general reagent suppliers.